BridgeBio Oncology Market Sentiment

BridgeBio Oncology Therapeutics Inc

BBOTNASDAQ

Trade with Public

$2.69

-0.005-0.19%

마지막 업데이트: Oct 28, 12:08 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리비교 주식 보고서

BridgeBio Oncology Market Sentiment - Benzinga

BridgeBio Oncology Market Sentiment

Market sentiment signals for BridgeBio Oncology (BBOT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▲ 11.8% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Outperform

10 analysts

Options Flow (P/C)

—

Avg Consensus PT

$21

+689.6%

Highest Price Target

$29

+980.1%

HC Wainwright & Co.

Lowest Price Target

$13

+384.2%

Morgan Stanley

Short Interest

11.8%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	Morgan Stanley	Sean Laaman—	+384.2%	$18 → $13	Maintained	Overweight
Oct 20, 2026	Oppenheimer	Mazahir Alimohamed—	+495.9%	$22 → $16	Maintained	Outperform
Sep 11, 2026	JP Morgan	Priyanka Grover—	+756.6%	$25 → $23	Maintained	Overweight
Sep 10, 2026	Leerink Partners	Andrew Berens—	+905.6%	$39 → $27	Maintained	Outperform
Sep 9, 2026	Canaccord Genuity	John Newman—	+644.9%	$23 → $20	Maintained	Buy
Sep 9, 2026	Raymond James	Sean McCutcheon—	+719.4%	$24 → $22	Maintained	Outperform
Sep 9, 2026	Stifel	Laura Prendergast—	+458.7%	$23 → $15	Maintained	Buy
Sep 9, 2026	Wedbush	David Nierengarten—	+831.1%	$25 → $25	Maintained	Outperform
Aug 14, 2026	JP Morgan	Priyanka Grover—	+831.1%	$27 → $25	Maintained	Overweight
Jul 8, 2026	JP Morgan	Priyanka Grover—	+905.6%	$27	Initiate	Overweight
Jun 22, 2026	Oppenheimer	Mazahir Alimohamed—	+719.4%	$22	Assumes	Outperform
May 11, 2026	Canaccord Genuity	John Newman—	+756.6%	$23	Initiate	Buy
Mar 6, 2026	HC Wainwright & Co.	Robert Burns—	+980.1%	$27 → $29	Maintained	Buy
Feb 11, 2026	Stifel	Laura Prendergast—	+756.6%	$23	Initiate	Buy
Jan 9, 2026	Raymond James	Sean McCutcheon—	+793.9%	$24	Initiate	Outperform
Dec 11, 2025	Wedbush	David Nierengarten—	+831.1%	$25 → $25	Maintained	Outperform
Dec 5, 2025	Morgan Stanley	Sean Laaman—	+644.9%	$20	Initiate	Overweight
Nov 25, 2025	Wedbush	David Nierengarten—	+831.1%	$25 → $25	Maintained	Outperform
Nov 13, 2025	Oppenheimer	Matthew Biegler—	+719.4%	$23 → $22	Maintained	Outperform
Sep 17, 2025	Leerink Partners	Andrew Berens—	+831.1%	$25	Initiate	Outperform
Sep 15, 2025	HC Wainwright & Co.	Robert Burns—	+905.6%	$27	Initiate	Buy
Sep 4, 2025	Oppenheimer	Matthew Biegler—	+756.6%	$23	Initiate	Outperform
Aug 18, 2025	Wedbush	David Nierengarten—	+831.1%	$25	Initiate	Outperform

BridgeBio Oncology Therapeutics Inc

뉴스

파트너 / 기고자

벤징가 글로벌

BridgeBio Oncology Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch